Remote psychophysical evaluation of olfactory and gustatory functions in early-stage coronavirus disease 2019 patients: the Bologna experience of 300 cases

Abstract Background An objective evaluation of coronavirus disease 2019 in the first days of infection is almost impossible, as affected individuals are generally in home quarantine, and there is limited accessibility for the operator who should perform the test. To overcome this limitation, a recently validated psychophysical self-administered test was used, which can be performed remotely in the assessment of early-stage coronavirus disease 2019 patients. Methods Olfactory and gustatory functions were objectively assessed in 300 patients in the first 7 days from coronavirus disease 2019 symptom onset. Results Seventy per cent of the patients presented olfactory and/or gustatory disorders. The dysfunctions detected were mainly complete anosmia (47 per cent) or ageusia (38 per cent). A significant correlation was found between taste dysfunction and female gender (odds ratio = 1.936, p = 0.014) and fever (odds ratio = 2.132, p = 0.003). Conclusion The psychophysical evaluation protocol proposed is an effective tool for the fast and objective evaluation of patients in the early stages of coronavirus disease 2019. Chemosensitive disorders have been confirmed to be frequent and early symptoms of the coronavirus infection, and, in a significant number of cases, they are the first or only manifestation of coronavirus disease 2019.

[1]  L. Vaira,et al.  In Response to Anosmia and Ageusia: Common Findings in COVID‐19 Patients , 2020, The Laryngoscope.

[2]  L. Vaira,et al.  In Response to: In Reference to Anosmia and Ageusia: Common Findings in COVID‐19 Patients , 2020, The Laryngoscope.

[3]  L. Vaira,et al.  In Response to Isolated Anosmia and Ageusia in COVID‐19 With Spontaneous Recovery , 2020, The Laryngoscope.

[4]  F. Biglioli,et al.  Olfactory and gustatory function impairment in COVID‐19 patients: Italian objective multicenter‐study , 2020, Head & neck.

[5]  Carol H. Yan,et al.  Reply to: Self‐reported olfactory loss in COVID‐19: is it really a favorable prognostic factor? , 2020, International forum of allergy & rhinology.

[6]  C. Hopkins,et al.  Self‐reported olfactory loss in COVID‐19: is it really a favorable prognostic factor? , 2020, International forum of allergy & rhinology.

[7]  F. Journé,et al.  Objective olfactory evaluation of self‐reported loss of smell in a case series of 86 COVID‐19 patients , 2020, Head & neck.

[8]  A. Sedaghat,et al.  Olfactory Dysfunction: A Highly Prevalent Symptom of COVID-19 With Public Health Significance , 2020, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[9]  N. Raad,et al.  Anosmia and the Need for COVID-19 Screening during the Pandemic , 2020, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[10]  C. Hopkins,et al.  Sniffing out the evidence; It's now time for public health bodies recognize the link between COVID-19 and smell and taste disturbance. , 2020, Rhinology.

[11]  P. Piombino,et al.  Potential pathogenesis of ageusia and anosmia in COVID‐19 patients , 2020, International forum of allergy & rhinology.

[12]  F. Bussu,et al.  Objective evaluation of anosmia and ageusia in COVID‐19 patients: Single‐center experience on 72 cases , 2020, Head & neck.

[13]  L. Vaira,et al.  The importance of olfactory and gustatory disorders as early symptoms of coronavirus disease (COVID-19) , 2020, British Journal of Oral and Maxillofacial Surgery.

[14]  F. Faraji,et al.  Self‐reported olfactory loss associates with outpatient clinical course in COVID‐19 , 2020, International forum of allergy & rhinology.

[15]  L. Vaira,et al.  Validation of a self‐administered olfactory and gustatory test for the remotely evaluation of COVID‐19 patients in home quarantine , 2020, Head & neck.

[16]  C. Hopkins,et al.  Alterations in Smell or Taste in Mildly Symptomatic Outpatients With SARS-CoV-2 Infection. , 2020, JAMA.

[17]  Richard L. Doty,et al.  Smell dysfunction: a biomarker for COVID‐19 , 2020, International forum of allergy & rhinology.

[18]  G. Manley,et al.  Smell and taste dysfunction in patients with COVID-19 , 2020, The Lancet Infectious Diseases.

[19]  C. Hopkins,et al.  Presentation of new onset anosmia during the COVID-19 pandemic. , 2020, Rhinology.

[20]  R. Carlier,et al.  Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study , 2020, European Archives of Oto-Rhino-Laryngology.

[21]  C. Hopkins,et al.  Anosmia and ageusia are emerging as symptoms in patients with COVID-19: What does the current evidence say? , 2020, Ecancermedicalscience.

[22]  L. Vaira,et al.  Anosmia and Ageusia: Common Findings in COVID‐19 Patients , 2020, The Laryngoscope.